AVAcore Technologies, Inc.

AVAcore Technologies develops innovative perioperative patient warming and neurovascular therapy devices. The company's flagship product, warmUP™, is an FDA-cleared 510(k) non-invasive fluid-based patient warming system designed to maintain normothermia during surgical procedures and recovery. The device features a closed-loop architecture with a patient-attached disposable arm warming sleeve that decouples from the base unit, enabling seamless patient transfer from preoperative through recovery phases without disrupting operating room airflow. warmUP™ incorporates triple-redundancy burn-prevention controls and eliminates forced-air contamination risks associated with traditional warming systems. The system is engineered for cost-efficiency, utilizing a single universal adult sleeve per surgical case to reduce supply chain complexity and inventory SKU proliferation. AVAcore is also developing combinational therapies leveraging proprietary vasodilation technology for acute migraine and pain management, currently under development and not yet FDA cleared. The company targets perioperative and acute care markets, with regulatory clearance under FDA 510(k) (K040911) and patent protection under U.S. Patents 8,603,150 and 9,463,134. Products are restricted to sale by or on the order of a physician under federal law.